Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
CNS Drugs|April 4, 2026
Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort StudyIzanne Roos, Sifat Sharmin, Serkan Ozakbas, et al.
JAMA Neurology|June 27, 2020
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple SclerosisCéline Louapre, Nicolas Collongues, Bruno Stankoff, et al.
CNS Drugs|September 18, 2021
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International CohortsSifat Sharmin, Mathilde Lefort, Johanna Balslev Andersen, et al.
Multiple Sclerosis and Related Disorders|June 11, 2021
The effectiveness of natalizumab vs fingolimod-A comparison of international registry studiesJohanna B Andersen, Sifat Sharmin, Mathilde Lefort, et al.
Nature Genetics|October 1, 2013
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis, Ashley H Beecham, Nikolaos A Patsopoulos, et al.
Pageof 9